(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RARLIBY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

RARLIBY

ST13

US500000090287803

Class

5

Filing

90287803

Registration

7525939

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

07/23/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

10/29/2020

Registration date

10/08/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/08/2024

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Carrigtohill Co. Cork,, IE

Examiner

SCHMIDT, JOHN JOSEPH

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

G. U. (pessoa física)
G. U. (pessoa física)

Representatives

Shelley Lai Gilead Sciences, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Publications

History of USPTO decisions and trademark events.

43 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/22/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/22/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/08/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/23/2024

PUBO

PUBLISHED FOR OPPOSITION

07/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/03/2024

IUCN

NOTICE OF ALLOWANCE CANCELLED

06/17/2024

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

06/12/2024

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

06/12/2024

APET

ASSIGNED TO PETITION STAFF

06/10/2024

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

04/30/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/01/2023

EX5G

SOU EXTENSION 5 GRANTED

11/30/2023

EXT5

SOU EXTENSION 5 FILED

11/30/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/30/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/06/2023

EX4G

SOU EXTENSION 4 GRANTED

05/04/2023

EXT4

SOU EXTENSION 4 FILED

05/04/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/04/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/16/2022

EX3G

SOU EXTENSION 3 GRANTED

11/14/2022

EXT3

SOU EXTENSION 3 FILED

11/14/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/14/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/07/2022

EX2G

SOU EXTENSION 2 GRANTED

05/05/2022

EXT2

SOU EXTENSION 2 FILED

05/05/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/05/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/27/2021

EX1G

SOU EXTENSION 1 GRANTED

10/25/2021

EXT1

SOU EXTENSION 1 FILED

10/25/2021

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/29/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/04/2021

PUBO

PUBLISHED FOR OPPOSITION

05/04/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/14/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/30/2021

DOCK

ASSIGNED TO EXAMINER

03/29/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/22/2020

NWAP

NEW APPLICATION ENTERED

11/02/2020

Continuous trademark protection

Get notified about every new filing that threatens RARLIBY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.